Schusterman Family Investments
VC Fund
New York, United States
Schusterman Family Investments is a VC fund in New York focused on GPU and Music. Schusterman Family Investments operates as a family investment office.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Schusterman Family Investments invests in
Stages Schusterman Family Investments invests in
Countries Schusterman Family Investments invests in
Round sizes
Round size
- Series C
- $37M–$45M
Investment Focus
Industry
- GPU 1 (13%)
- Music 1 (13%)
- Sales 1 (13%)
- Medical 1 (13%)
- Big Data 1 (13%)
Stage
- Series C 2 (25%)
- Funding Round 2 (25%)
- Series A 1 (13%)
- Series B 1 (13%)
- Series D 1 (13%)
Country
- United States 3 (38%)
- Israel 1 (13%)
- Sweden 1 (13%)
- Turkey 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Closed Loop Partners
|
Closed Loop Partners invests in sustainable consumer goods, advanced recycling technologies and the development of the circular economy. | Feb 10, 2025 | |
Ratio Therapeutics
|
Ratio Therapeutics develops radiotherapeutics for the treatment of cancers. They engaged in research and development platforms, trillium and macropa, enable the imaging, discovery, and advancement of radiopharmaceuticals. It enables doctors to detect a wide range of epithelial-derived cancers, such as breast, pancreatic, lung, colon cancers, andmore. | $50M / Series B / Jan 17, 2024 | |
SQream Technologies
|
SQream Technologies is a provider of a data analytics acceleration platform that enables enterprises to gain insights from their data stores.It delivers a flexible database for huge dataset analytics. Enterprises use SQream DB, a GPU database created by SQream Technologies to analyze data-sets. SQream DB delivers business intelligenceacceleration for smart, informed, near real-time time decision making based on large data sets. With minimum cost, hardware, and infrastructure changes required, anyone can ingest, compress, store, and analyze large data-sets in near real-time. The company works using broadly adopted production standards like SQL, Java, and Python.The Tel Aviv, Tel Aviv-located company was established by Razi Shoshani, Kostya Varakin, and Ami Gal in 2010. | $45M / Series C / Sep 12, 2023 | |
Soundtrack
|
Soundtrack Your Brand is a Spotify joint venture and the exclusive provider of Spotify Business and Spotify Enterprise. We connect brands and fans, and our vision is to grow the music market and thereby support artists, so that they can give the world more great music | $15M / Venture - Series Unknown / Jun 14, 2023 | |
Healthy.io
|
Healthy.io is a pioneer in turning the smartphone camera into a clinical grade medical device. Founded in 2013 by founder and CEO, Yonatan Adiri, it took us only three years to reach from idea to global revenues through successful clinical trials. Our first product, Dip.io, is the world’s first clinically approved home urinalysis kit. The producteffectively turns the smartphone into a clinical grade urinalysis device, enabling the layperson to conduct clinically required urine testing with a simple smartphone scan. Dip.io was followed by ACR - a second urinalysis test that lets people with diabetes or high blood pressure reliably test themselves at home for kidney disease. The product achieved 99% usability success and is being rolled out for large population screening in Europe, using digital technology to change the dynamics of chronic kidney disease prevention. Our second product family - Chronic wound monitoring - is an assessment tool to analyze chronic wounds over time and facilitate better care coordination. | $5M / Series D / May 03, 2023 | |
|
Ratio Therapeutics
|
Ratio Therapeutics develops radiotherapeutics for the treatment of cancers. They engaged in research and development platforms, trillium and macropa, enable the imaging, discovery, and advancement of radiopharmaceuticals. It enables doctors to detect a wide range of epithelial-derived cancers, such as breast, pancreatic, lung, colon cancers, andmore. | $20M / Series A / Feb 01, 2023 | |
VavaCars
|
VavaCars is an online used car transaction platform | $37M / Series C / Sep 14, 2022 | |
|
Healthy.io
|
Healthy.io is a pioneer in turning the smartphone camera into a clinical grade medical device. Founded in 2013 by founder and CEO, Yonatan Adiri, it took us only three years to reach from idea to global revenues through successful clinical trials. Our first product, Dip.io, is the world’s first clinically approved home urinalysis kit. The producteffectively turns the smartphone into a clinical grade urinalysis device, enabling the layperson to conduct clinically required urine testing with a simple smartphone scan. Dip.io was followed by ACR - a second urinalysis test that lets people with diabetes or high blood pressure reliably test themselves at home for kidney disease. The product achieved 99% usability success and is being rolled out for large population screening in Europe, using digital technology to change the dynamics of chronic kidney disease prevention. Our second product family - Chronic wound monitoring - is an assessment tool to analyze chronic wounds over time and facilitate better care coordination. | $45M / Series D / Feb 01, 2022 |
Co-Investors
Aleph
2 deals together
Balderton Capital
1 deal together
Blumberg Capital
1 deal together
Bristol-Myers Squibb
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Schusterman Family Investments invest in?
Schusterman Family Investments invests primarily in GPU, Music and Sales startups, most often at Series C and Funding Round stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Schusterman Family Investments's check size?
Schusterman Family Investments typically joins rounds of $37M–$45M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Schusterman Family Investments participates in.
When did Schusterman Family Investments last invest?
The most recent investment recorded for Schusterman Family Investments closed in Feb 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
